MedTrace Logo

Reperfusion Syndrome and Vasoplegic Syndrome in Liver Transplant Surgery

NCT05658120 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 246

Last updated 2023-02-21

No results posted yet for this study

Summary

The incidence of postreperfusion syndrome (PRS) and vasoplegic syndrome (VS) is unknown, and occasionally can be confused since these syndromes share some hemodynamic characteristics. In these cases, monitoring with Swan Ganz catheter may be useful to make the differential diagnosis. The main outcome was to analyze reperfusion syndrome and vasoplegic syndrome in patients receiving vasoactive support during liver transplant surgery, in terms of incidence, risk factors and postoperative complications.

Conditions

  • Postperfusion Syndrome

Interventions

DRUG

noradrenaline/adrenaline

norepinephrine adrenaline in patients with Swan-Ganz catheter monitoring during liver transplantation

Sponsors & Collaborators

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-13
Primary Completion
2022-12-13
Completion
2023-02-18

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05658120 on ClinicalTrials.gov